Jeil Pharmaceutical acquires European EDQM approval for ‘cephalosporin’ ingredient

Published: 2017-07-13 14:30:43

Updated: 2017-07-13 14:30:43

Jeil Pharmaceutical(CEO/President Suk-Jae Sung) announced ‘cefpodoxime’ manufactured at the Baekam Factory’s ‘cephalosporin’ manufacturing facility located in Cheoin-gu, Yongin-si, Gyeonggi-do acquired approval from the European Directorate for the Quality of Medicines(EDQM).

The company had carried out a procedure to acquire the EDQM’s Certificates of Suitability for ‘cefpodoxime,’ its cephal...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.